^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

vantictumab (OMP-18R5)

i
Other names: OMP-18R5
Company:
Mereo Biopharma, Novartis
Drug class:
Wnt signalling pathway inhibitor